Home > News > Latest > MSD pulls plug on cholesterol drug anacetrapib

MSD pulls plug on cholesterol drug anacetrapib

MSD has decided to pull the plug on its late-stage cholesterol drug anacetrapib after a lacklustre performance in clinical trials. The company said it would not file for approval of the investigational cholesteryl ester transfer protein (CETP) inhibitor on the back of a review of its clinical profile that included discussions with external experts.